Sector exposure

Pharmazeutika

1 funds with Pharmazeutika exposure · weighted average allocation 10.4% · 1164th largest sector ranked across tracked funds

Funds
1
Avg weight
10.4%
Sector rank
#1164 of 1277
AI Analysis · Pharmazeutika Powered by Claude · live
Generating analysis…

AI outlook will appear here once data is loaded.

Momentum
—
Valuation
—
Fund sentiment
—
community voting · coming soon
Build a screen from this →

Top Pharmazeutika-exposed funds

Sorted by sector weight · 1 funds total
Fund
Manager
Sector weight
1Y return
AM
apo Medical Opportunities
LU0220663669
IPConcept
10.4%
+14.6%
Top Pharmazeutika Holdings Across Funds
—
PROTAGONIST THERAPEUTICS INC.
Unknown
5.92%
in 1 funds
—
ELI LILLY AND COMPANY
Unknown
5.27%
in 1 funds
—
INSMED INCORPORATED
Unknown
3.99%
in 1 funds
—
UCB S.A.
Unknown
3.42%
in 1 funds
—
UNITEDHEALTH GROUP INCORPORATED
Unknown
3.28%
in 1 funds
—
ASCENDIS PHARMA A/S ADR
Unknown
3.17%
in 1 funds
—
ARGENX SE SP.ADR/1 -,10
Unknown
2.94%
in 1 funds
—
TRAVERE THERAPEUTICS INC.
Unknown
2.93%
in 1 funds
Conviction Score vs MSCI Benchmark
Fund weight vs MSCI World benchmark (0%)
apo Medical Opportun..
+10.4%
Performance Chart
Top 1-fund composite (rebased to 100, equal-weighted) Pharmazeutika ETF (benchmark) Real fund NAV data 2025-05-30 → 2026-03-31
Pharmazeutika Sector News
Loading news...
FundBenchmark
Data updated in real-time from FMP, FE fundinfo & MSCI